Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Cramer Stops Trading: Amgen Coverage Halted Amid Philosophical Differences

Guavy AI Editorial Team
Instruments
AMGN
Share

CNBC's Jim Cramer has announced that he is stopping his coverage of Amgen (AMGN) stocks. In an unexpected move, Cramer cited 'philosophical differences' as the reason for halting his commentary on the biotech company.

This decision comes after Cramer had been following and commenting on Amgen's performance in the past. The exact nature of these philosophical differences is not specified in the announcement.

More on Stocks

Stocks just now

Morgan Stanley Lifts Honeywell International Price Target to $250

Stocks 1m ago

Amazon Steals the Spotlight with Affordable Mirror Alternative

Stocks 1m ago

Florida Bakery Accuses Amazon Driver of Theft Over Free Cake Pop Mix-Up

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy